National Cancer Center Korea is a South Korean company located in Goyang-si and ultimately controlled by the Government of South Korea. The firm provides clinical and medical research services.

Genisphere is a nanotechnology company providing innovative tools for targeted drug delivery, clinical diagnostics and life science research based on the company’s 3DNA nanoparticle platform. Genisphere's unique, IP-protected, 3DNA technology has broad applicability to improve the sensitivity in immunoassay and nucleic acid detection platforms, as well as to deliver therapeutics in a highly specific manner. Genisphere has successfully out-licensed several reagent kits to the research market, and provides customized products to improve the limit of detection of high-sensitivity lateral flow point-of-care tests, enabling their commercialization. Genisphere's diagnostic partners have a competitive advantage due to 3DNA’s ability to improve their test’s sensitivity, with minimal additional costs and no alterations to end user protocols. For targeted therapeutics, Genisphere provides a fully customizable all-DNA drug delivery platform. Genisphere's robust nanocarrier delivers small drug, RNAi and gene construct therapeutics with greatly improved efficacy and reduced toxicity. The company is continuing to seek partnerships with biotechnology and pharmaceutical companies that could benefit from Genisphere's platform technology.

Cell Microsystems is an early growth stage company that develops, manufactures, and markets innovative products for single-cell biology. The company’s proprietary CellRaft™ Technology enables high-efficiency sorting and isolation of single cells under standard culture conditions resulting in unperturbed phenotypes and high viability. Coupled with the company’s automated imaging platform, a user can select a cell in real-time and ‘track and trace’ that cell through imaging, collection, and downstream analysis. By sorting during real-time imaging, no cells are wasted enabling single-cell isolation from even small, precious samples. The CellRaft Technology offers scalable solutions making cell separation technology available for every lab.

Tempus Labs, Inc. enagegs in the development of a platform that analyzes clinical and molecular data points focusing on cancer research. It connects physicians treatment options and relevant insights for patients based on their unique molecular profile and analytics and machine-learning algorithms. The firm offers genomic sequencing, clinical data structuring, image recognition, biological modeling, and time trial program. The company was founded by Bradley A. Keywell and Eric P. Lefkofsky in 2015 and is headquartered in Chicago, IL.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Beijing Zhenzhi Medical Technology Co. Ltd. is a company headquartered in China. The firm develops medical technology solutions.

Beijing Geek Gene Technology Co., Ltd., established on 2016-06-30, Business scope includes technology development,technology transfer,technical consulting,Technical Services,Technology Promotion,Technical Training(Cannot be recruited nationwide);Medical Research and Experimental Development;Organize cultural and artistic exchange activities(Does not include commercial performances);Application software service;Basic software service;software development;Computer System Services;Undertake exhibition and display activities;computer animation design;product design;business management;market survey;Economic and Trade Consulting;buisness planning;Sales of machinery and equipment,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),electronic product,computer,Software and Auxiliary Equipment;Conference Services;Internet culture management;Basic Telecom Services;Internet information service.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Internet culture management,Basic Telecom Services,Internet information services and projects subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Beijing Zeqiao Medical Technology Co., Ltd., established on 2008-07-04, The scope of business includes engaging in medical information,Technology development of computer hardware and software,Technology Promotion,Technical Services,technology transfer;artificial intelligence,Technological development of robots;Computer System Services;Basic software service;Application software service;internet data service(Data Centers in Internet Data Services,PUEvalue in1.4Except for the above cloud computing data centers);Information processing and storage support services(Data centers in information processing and storage support services,PUEvalue in1.4Except for the above cloud computing data centers);Information Technology Consulting Services;software development;Investment,investment management;business management;design,make,acting,Place an ad;Organize cultural and artistic exchange activities(without show);Conference Services;Undertake exhibition display service;Health Advisory(Except for medical treatment activities subject to approval);public relations service;business inquiries;Trade Consulting;photography service;Corporate Image Planning;marketing planning;Television planning;market survey;Sales Class I,Class II medical device,Disinfectant(Except for licensed items);Educational Consulting;Import and export,Agent import and export,Technology Import and Export;publication retail;Wholesale Publications;sell food;engage in Internet cultural activities;Radio and television program production and management;The second type of value-added telecommunications services.(Market entities independently choose business projects in accordance with the law,Carry out business activities;engage in Internet cultural activities,sell food;Radio and television program production and management;The second category of value-added telecommunication services and projects subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Shanghai Jingzhou Gene Technology Co., Ltd., established on 2017-06-02, Business scope includes licensed projects:Class III medical device business;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:genetic technology,Technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer,computer,Software and Auxiliary Equipment,Instrumentation,Chemical Products(No licensed chemical products),Pharmaceutical equipment,Specialty Chemicals(Free of Hazardous Chemicals),Sales of Office Supplies,Conference and Exhibition Services,Sales of Class I Medical Devices,Sales of Class II Medical Devices,medical equipment,Equipment,Leases of non-residential real estate,Office equipment rental service,Information Consulting Service(Not including licensing information consulting services),business management,Project planning and public relations services,Instrumentation,General Equipment,Repair of special equipment,Information system operation and maintenance services,electronic,Mechanical equipment maintenance(No special equipment).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Zhongshan Ophthalmic Center, part of Sun Yat-Sen University, is a Chinese company located in Guangzhou that operates hospitals.

Shanghai Yuanqi Bio-Pharmaceutical Co. Ltd., a subsidiary of Mingyuan Medicare Development Co. Ltd., is a company headquartered in Shanghai, China, that develops molecular diagnostic products. The firm was acquired by SHMY Healthdigit Biochips Co., Ltd. on November 23, 2011 for $47.79 million.

Zhejiang Free Trade Zone Ruisai Biomedical Technology Co., Ltd., established on 2018-06-06, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biochemical product technology research and development;Engineering and Technology Research and Experimental Development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals);Import and export;Technology Import and Export;Import and export agency;R&D and application of cell technology;Human stem cell technology development and application(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shanghai Liwen Biotechnology Co., Ltd., established on 2013-08-22, Business scope includes general items:Engaged in technology development in the professional field of biotechnology,technology transfer,technical consulting,Technical Services;Medical Research and Experimental Development;Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals);Instrumentation,electronic product,Sales of Class II Medical Devices;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

New Geyuan (Nanjing) Biotechnology Co., Ltd., established on 2018-01-23, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:software development;Instrument Manufacturing;Engineering and Technology Research and Experimental Development;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Instrument sales;Experimental analysis instrument sales;Manufacturing of experimental analysis instruments;Specialty Chemicals Sales(Free of Hazardous Chemicals);Production of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)